| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.1922 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.1922 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.1922 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.1922 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.1922 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.1922 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.1922 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.1922 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.1922 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.1922 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.2707 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.2970 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.3256 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.5213 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.5472 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.5511 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.5695 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.5707 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.5751 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.5941 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.5969 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6112 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6115 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6277 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6298 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6435 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6486 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6529 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6572 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6715 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6744 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6790 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6797 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6828 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.6956 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7043 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7115 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7118 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7209 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7325 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7400 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7456 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7623 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7657 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7706 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7824 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7847 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7848 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7865 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7877 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7885 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7923 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7928 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7968 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.7982 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8066 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8147 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8206 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8253 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8301 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8373 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8377 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8404 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8505 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8538 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8540 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8607 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8650 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8719 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8738 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8741 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8809 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8812 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8831 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8831 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8843 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8844 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8871 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8895 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8915 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8924 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8955 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.8983 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9027 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9079 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9228 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9326 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9347 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9362 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9404 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9467 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9861 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9867 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9897 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 0.9928 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0000 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0133 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0155 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0190 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0248 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0259 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0283 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0313 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0415 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0442 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0459 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0548 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0549 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0589 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0630 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0726 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0773 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0810 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0922 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.0996 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1021 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1097 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1102 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1301 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1323 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1406 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1479 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1502 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1532 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1950 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.1994 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2013 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2027 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2030 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2042 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2152 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2256 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2330 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2741 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2808 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.2971 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.3049 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.3101 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.3228 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.3343 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.3372 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.3386 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.3445 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.3694 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.3816 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.3914 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4041 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4043 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4119 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4255 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4573 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4588 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4694 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4695 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4842 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4862 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.4873 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.5122 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.5260 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.5263 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.5452 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.6092 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.6183 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.6226 | scaled units | High-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.6431 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.6476 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.6553 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.6569 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.7091 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.7320 | scaled units | High-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.7481 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.7617 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.7786 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.8094 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.8291 | scaled units | Low-Dose | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.8468 | scaled units | Placebo | -0.5HR |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.9080 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.9159 | scaled units | Low-Dose | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 1.9717 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 2.0021 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 2.1977 | scaled units | Placebo | BASELINE |
| Reversed phase POSITIVE ION MODE | 1-methylhistidine | 2.2152 | scaled units | Placebo | +47HR POST INFUSION |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|